GELITA will showcase its rebranded Controlled Release Portfolio of performance products for superior softgels at CPhl in Milan, Italy (October 08-10). This includes RXL® Ultra for substantially zero crosslinking – even with challenging, plant-based fills. Expert speakers will explain how to overcome these challenges in their theatre presentation, while GELITA Health representatives will be on hand throughout the event to show own label customers how to achieve success in the vibrant collagen supplements market with GELITA Bioactive Collagen Peptides (BCP®).
Visitors to booth 10G72 can explore the advantages of GELITA’s newly rebranded Controlled Release Portfolio. Enabling manufacturers to choose when and where in the body softgel fills are released, it comprises:
- DELASOL®: the only product on the market that creates enteric softgels in a single step, with no need for additional coating, making production more efficient,
- RAPISOL®: for when rapid fill release is the goal,
- RXL® Portfolio, including RXL® Ultra: for reduced crosslinking, no matter how challenging the
“We have streamlined and strengthened the branding across our Controlled Release
Portfolio to highlight each product’s particular benefits,” explains Dr Stephan Hausmanns, Head of Global Marketing & Innovation Management at GELITA Performance Solutions. “This will also enable us to add additional brands to the portfolio as we develop further innovations in the future. Stay tuned for more to come.”
Alongside its Controlled Release Portfolio, GELITA will present EASYSEAL®, a ground-breaking gelatin that dramatically reduces leakers during softgel production and beyond.
No More Crosslinking: Product Innovation Presentation
In their session at 1:45 p.m. on October 8 (Manufacturing & Outsourcing Theatre, Hall 5), GELITA experts Dennis Witthoeft and Dr Katrin Kaspar will discuss “Heavy Crosslinking due to novel Plant Extracts – Challenge Accepted with RXL® Ultra”. RXL® Ultra sets a benchmark in anti-crosslinking performance. It maintains the known benefits of softgel gelatin while solving even the most extreme crosslinking challenges. The result is reliable products with superior stability and shelf-life.
Customizable Solutions for Successful Supplements
Those with an interest in private label supplements can explore exciting opportunities with representatives from GELITA Health. The GELITA subsidiary specializes in producing customized finished products for private label customers or under GELITA Health global brands like QYRA®, CH-Alpha®, convitar® and ShapeUp®. All products contain GELITA’s BCP®, which have scientifically proven targeted functionalities for different needs. They enable success in the sectors beauty-from-within, mobility and sports nutrition.
